APW
NAUT icon

Aventura Private Wealth’s Nautilus Biotechnolgy NAUT Stock Holding History

Aventura Private Wealth’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-350
Closed -$296 – 890
2025
Q3 		$296 Hold
350
– – ﹤0.01% 776
2025
Q2 		$254 Hold
350
– – ﹤0.01% 749
2025
Q1 		$301 Hold
350
– – ﹤0.01% 749
2024
Q4 		$588 Buy
+350
New +$837 ﹤0.01% 681

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return

Aventura Private Wealth's NAUT Position: Q4 2025 in Review

Aventura Private Wealth sold out of Nautilus Biotechnolgy (NAUT) in Q4 2025, closing a stake of 350 shares — an estimated $296 sold.

Aventura Private Wealth first reported a position in NAUT in Q4 2024 and held it in 4 quarters. The position peaked at $588 in Q4 2024. 68 funds tracked by Wall St. Rank hold NAUT as of Q4 2025.

  • Aventura Private Wealth reported no remaining Nautilus Biotechnolgy position as of Q4 2025 after selling out during the quarter.
  • Aventura Private Wealth sold 350 Nautilus Biotechnolgy shares in Q4 2025, an estimated $296.
  • Aventura Private Wealth first reported a position in Nautilus Biotechnolgy in Q4 2024 and held it in 4 quarters.
  • Aventura Private Wealth's Nautilus Biotechnolgy position peaked at $588 in Q4 2024.
  • 68 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2025.

Based on Aventura Private Wealth's 13F filing for Q4 2025, filed 7 Jan 2026.